Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|September 29, 2019
Epigenetics of Urological CancersWolfgang A Schulz, Karina D Sørensen
Bioinformatics (Oxford, England)|January 8, 2016
PINCAGE: probabilistic integration of cancer genomics data for perturbed gene identification and sample classificationMichał P Świtnicki, Malene Juul, Tobias Madsen, et al.
Diagnostics (Basel, Switzerland)|January 21, 2022
Evaluation of Predictors of Biochemical Recurrence in Prostate Cancer Patients, as Detected by <sup>68</sup>Ga-PSMA PET/CTMads T Christensen, Mads R Jochumsen, Søren Klingenberg, et al.
International Journal of Cancer|March 24, 2019
A five-microRNA model (pCaP) for predicting prostate cancer aggressiveness using cell-free urineJacob Fredsøe, Anne K I Rasmussen, Peter Mouritzen, et al.
Clinical Epigenetics|October 24, 2019
Epigenetic silencing of MEIS2 in prostate cancer recurrenceMaibritt Nørgaard, Christa Haldrup, Marianne Trier Bjerre, et al.
Scientific Reports|September 7, 2022
Predicting Grade group 2 or higher cancer at prostate biopsy by 4Kscore in blood and uCaP microRNA model in urineJacob Fredsøe, Martin Rasmussen, Amy L Tin, et al.
Frontiers in Oncology|April 12, 2021
High-Throughput and Automated Acoustic Trapping of Extracellular Vesicles to Identify microRNAs With Diagnostic Potential for Prostate CancerAnson Ku, Jacob Fredsøe, Karina D Sørensen, et al.
Acta Oncologica (Stockholm, Sweden)|October 6, 2022
Recurrence rate after radical prostatectomy following primary staging of high-risk prostate cancer with <sup>68</sup>Ga-PSMA PET/CTSøren Klingenberg, Jacob Fredsøe, Karina D Sørensen, et al.
BJU International|January 19, 2016
Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressivenessTine M Storebjerg, Søren Høyer, Pia Kirkegaard, et al.
The Journal of Pathology|July 13, 2021
Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factorsLine B Andersen, Maibritt Nørgaard, Martin Rasmussen, et al.
Pageof 5